Basket Trial of IDX-1197, a PARP Inhibitor, in Patients With HRR Mutated Solid Tumors (VASTUS)
NCT04174716
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
108
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Homologous Recombination Repair Gene Mutation
Homologous Recombination Deficiency
Interventions
DRUG:
IDX-1197
Sponsor
Idience Co., Ltd.